Next Science Limited

ASX:NXS.AX

0.38 (AUD) • At close April 16, 2024
Bedrijfsnaam Next Science Limited
Symbool NXS.AX
Munteenheid AUD
Prijs 0.38
Beurswaarde 110,844,100
Dividendpercentage 0%
52-weken bereik 0.18 - 0.76
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Harry Thomas Hall
Website https://www.nextscience.com

An error occurred while fetching data.

Over Next Science Limited

Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound

Vergelijkbare Aandelen

Genetic Signatures Limited logo

Genetic Signatures Limited

GSS.AX

0.7 AUD

Alcidion Group Limited logo

Alcidion Group Limited

ALC.AX

0.044 AUD

Volpara Health Technologies Limited logo

Volpara Health Technologies Limited

VHT.AX

1.14 AUD

Probiotec Limited logo

Probiotec Limited

PBP.AX

2.85 AUD

Medical Developments International Limited logo

Medical Developments International Limited

MVP.AX

0.55 AUD

AVITA Medical, Inc. logo

AVITA Medical, Inc.

AVH.AX

2.98 AUD

ImpediMed Limited logo

ImpediMed Limited

IPD.AX

0.094 AUD

Healthia Limited logo

Healthia Limited

HLA.AX

1.795 AUD

Mach7 Technologies Limited logo

Mach7 Technologies Limited

M7T.AX

0.665 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)